HeadSense Secures Financing for Non-Invasive Neurological Monitor
7/8/2013 10:54:23 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
NETANYA, Israel--(BUSINESS WIRE)--HeadSense, an early stage company developing a non-invasive neurological monitor focused initially on an intracranial pressure (ICP) application, today announced it closed financing led by Pontifax, a leading Israeli VC; GE Ventures of Menlo Park, California, USA; Everett Partners, an investment group based out of Akron, Ohio, USA; and JuMaJo, an investment group from Hamburg, Germany. HeadSense will use the investment to continue to expand its revolutionary work in bringing to market its non-invasive ICP monitor. HeadSense’s device includes an earbuds-like disposable unit that is placed in the patient’s ears. The device generates an acoustic signal that is circulated through the head and then is picked up in the other ear using an acoustic sensor. The data generated from the signal can then be analyzed in real-time from a tablet or smartphone.
Help employers find you! Check out all the jobs and post your resume.
comments powered by